Back to Search
Start Over
AB0799 Alterations of body composition in scleroderma patients are associated with disease activity and physical activity but not with lung involvement
- Source :
- Scleroderma, myositis and related syndromes.
- Publication Year :
- 2018
- Publisher :
- BMJ Publishing Group Ltd and European League Against Rheumatism, 2018.
-
Abstract
- Background Systemic sclerosis (SSc) is characterised by fibrosis of the skin and visceral organs, especially digestive tract, and musculoskeletal and lung involvement, which limit mobility/self-sufficiency of patients and can have a negative impact on body composition and physical activity. Objectives To assess body composition and physical activity of SSc patients and healthy controls (HC). Methods 59 patients with SSc [50 females; mean age 52.5; disease duration 6.7 years; limited cutaneous (lcSSc, 34)/diffuse cutaneous (dcSSc, 25)] and 59 age-/sex-matched HC (50 females, mean age 52.5) without rheumatic diseases were included. SSc patients fulfilled ACR/EULAR 2013 criteria. Anthropometric parameters and body composition were assessed (by densitometry: iDXA Lunar, and by bioelectric impedance: BIA-2000-M), and physical activity was evaluated using Human Activity Profile (HAP) questionnaire. Routine biochemistry analysis was performed after 8 hours of fasting. Pulmonary function and diffusing capacity of lung were examined, disease activity was evaluated by ESSG activity index. Data are presented as mean ±SD. Results Compared to HC, patients with SSc had significantly lower body-mass index (BMI:27.9±8.3 vs. 22.4±4.3 kg/m2, p Conclusions Compared to healthy age-/sex-matched individuals we found significant negative changes in body composition of our SSc patients, which are associated with their disease activity and physical activity, and could reflect their nutritional status, and gastrointestinal and musculoskeletal involvement. We found no significant association between lung involvement and changes of body composition. Acknowledgements Supported by AZV-16–33574A and SVV-260373 Disclosure of Interest None declared
- Subjects :
- medicine.medical_specialty
Lung
business.industry
medicine.disease
Gastroenterology
Scleroderma
Pulmonary function testing
Human Activity Profile
Disease activity
03 medical and health sciences
0302 clinical medicine
medicine.anatomical_structure
Fibrosis
030220 oncology & carcinogenesis
Internal medicine
Diffusing capacity
medicine
business
Densitometry
030217 neurology & neurosurgery
Subjects
Details
- Database :
- OpenAIRE
- Journal :
- Scleroderma, myositis and related syndromes
- Accession number :
- edsair.doi...........edcb1512ba118825f306897e82cb392a
- Full Text :
- https://doi.org/10.1136/annrheumdis-2018-eular.6978